Image analysis for the detection of increased erythrocyte, leukocyte and platelet adhesiveness/aggregation in the peripheral blood of patients with diabetes mellitus

Acta Diabetologica

Volumn 38, Issue 3, 2001, Pages 129-134

  Fusman, R ^a   Rotstein, R ^a   Elishkewich, K ^a   Zeltser, D ^a   Cohen, S ^a   Kofler, K ^a   Avitzour, D ^b   Arber, N ^a   Berliner, S ^a   Shapira, I ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Timotim Technologies   (Israel)

Author keywords

Cell aggregation; Diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CELL AGGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; ERYTHROCYTE ADHESIVENESS; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LEUKOCYTE ADHERENCE; MALE; PRIORITY JOURNAL; THROMBOCYTE ADHESIVENESS;

ADULT; CELL ADHESION; DIABETES MELLITUS; ERYTHROCYTE AGGREGATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ADHESIVENESS; PLATELET AGGREGATION; REFERENCE VALUES;

EID: 0035671333     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920170009     Document Type: Article

References (32)

1. Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease
2. Diabetes mellitus: Mean erythrocyte aggregation, glycometabolic pattern, red cell Ca2+ content, and erythrocyte membrane dynamic properties
3. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus
4. Increased granulocyte aggregation in vitro in diabetes mellitus
5. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus
6. Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions
7. Blood rheology in vitro and in vivo
8. The activated megakaryocyte-platelet system in vascular disease: Focus on diabetes
9. Recommendation of measurement of erythrocyte sedimentation rate of human blood
10. Gerinnungsphysiologische shnellmethode zur bestimmung des fibrinogens
11. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum
12. The phenomenon of leukergy: Induction and detection of leukocyte aggregation in whole human blood
13. Combined leukocyte and erythrocyte aggregation in the peripheral venous blood during sepsis. A clue to the presence of a commonly shared adhesive protein(s)
14. INFLAMET: An image analyzer to display erythrocyte adhesiveness/aggregation
15. The inflammation meter: Novel technique to detect the presence of infection/inflammation in patients without leukocytosis but with an increased leukocyte adhesiveness/aggregation
16. The inflammation meter (INFLAMET): A new diagnostic approach to reveal the presence of an inflammatory response and for the assessment of its intensity
17. Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes
18. Phospholipid asymmetry in health and disease
19. Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes
20. Red blood cell aggregation and primary hyperlipoproteinemia
21. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals
22. Coagulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects
23. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin
24. Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia
25. Mechanism of erythrocyte aggregation and sedimentation
26. Possible role of fibrinogen in the aggregation of white blood cells
27. Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
28. Correlated expression of adhesive properties for both white and red blood cells during inflammation
29. Increased erythrocyte adhesiveness/aggregation in the peripheral venous blood of patients with ischemic heart disease and an eventful course
30. The erythrocyte adhesiveness/aggregation (EAAT) in the peripheral blood of patients with ischemic brain events
31. The erythrocyte adhesiveness/aggregation (EAAT) in the peripheral blood of patients with ischemic heart and brain disease with normal fibrinogen concentrations
32. Electronic counter-related pseudoleukopenia: More than a rare occurrence